Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma

BACKGROUND: In a randomized phase III trial of sunitinib vs interferon-alfa (IFN-α) in metastatic renal cell carcinoma (mRCC), better baseline quality of life (QoL) was predictive of longer survival. Using this dataset, we have developed a novel prognostic tool that establishes a relationship betwee...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Cella, D, Bushmakin, A G, Cappelleri, J C, Charbonneau, C, Michaelson, M D, Motzer, R J
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2012
Fag:
Clinical Studies
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3322947/
https://ncbi.nlm.nih.gov/pubmed/22240794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.589
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker